Calumet director sells 4,240 shares under 10b5-1
Calumet, Inc. director Daniel J. Sajkowski reported an open-market sale of 4,240 shares of common stock at a weighted average price of $36.16 per share.
Rhea-AI Filing Summary
Calumet, Inc. director Daniel J. Sajkowski reported an open-market sale of 4,240 shares of common stock at a weighted average price of $36.16 per share. After this transaction, he directly holds 77,718 shares, so the sale represents a relatively small portion of his position.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2025, when the stock closed at $19.08 per share. The shares were sold in multiple trades at prices ranging from $35.72 to $36.33 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 4,240 shares
Net Sell
1 txn
Insider
Sajkowski Daniel J
Role
Director
Sold
4,240 shs ($153K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.01 per share | 4,240 | $36.16 | $153K |
Holdings After Transaction:
Common Stock, par value $0.01 per share — 77,718 shares (Direct)
Footnotes (2)
- F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025. The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market, on the date the Rule 10b5-1 trading plan was adopted by the reporting person was $19.08 per share.
- F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.72 per share to $36.33 per share. The reporting person undertakes to provide to Calumet, Inc., any security holder of Calumet, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Key Figures
Shares sold: 4,240 shares
Weighted average sale price: $36.16 per share
Post-transaction holdings: 77,718 shares
+2 more
5 metrics
Shares sold
4,240 shares
Open-market sale of common stock
Weighted average sale price
$36.16 per share
Average price across multiple sale transactions
Post-transaction holdings
77,718 shares
Direct ownership after the sale
Sale price range
$35.72–$36.33 per share
Price range of individual sale trades
Stock price on plan adoption
$19.08 per share
Closing price on November 18, 2025
Key Terms
Rule 10b5-1 trading plan, weighted average price, Nasdaq Global Select Market, open-market sale
4 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Nasdaq Global Select Market market
"The closing price of one share of Calumet, Inc. common stock, as reported on the Nasdaq Global Select Market"
A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.
open-market sale financial
"transaction_action: open-market sale"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Calumet, Inc. (CLMT) disclose in this Form 4?
Calumet, Inc. reported that director Daniel J. Sajkowski sold 4,240 shares of common stock. These were open-market sales at a weighted average price of $36.16 per share, executed under a pre-arranged Rule 10b5-1 trading plan.
Was the CLMT insider sale by Daniel J. Sajkowski made under a Rule 10b5-1 plan?
Yes. The filing states the sales were effected under a Rule 10b5-1 trading plan adopted on November 18, 2025. That adoption date’s closing stock price was $19.08 per share on the Nasdaq Global Select Market.
What does the weighted average price mean in this Calumet (CLMT) Form 4?
The filing reports a weighted average sale price of $36.16 per share, meaning shares were sold in multiple trades at slightly different prices. Those trades occurred between $35.72 and $36.33 per share, and the average reflects all such transactions combined.
Who is the insider involved in this Calumet, Inc. (CLMT) Form 4 transaction?
The insider is Daniel J. Sajkowski, identified in the filing as a director of Calumet, Inc. He reported selling 4,240 shares of the company’s common stock and retaining direct ownership of 77,718 shares after the transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
